Jasper Therapeutics (JSPR) PT Lowered at RBC Capital as 'BEACON Investigation Raises Further Questions' Nov 11, 2025 08:41AM
Jasper Therapeutics to Present at Upcoming Investor Conferences May 14, 2025 04:30PM
Jasper Therapeutics (JSPR) PT Lowered to $48 at RBC Capital; Stock Pressured Following BEACON's Initial Data Jan 9, 2025 11:40AM
Jasper Therapeutics (JSPR) PT Lowered to $68 at RBC Capital Aug 14, 2024 06:25AM
2Q24 U.S. biotech earnings preview Jul 9, 2024 07:00PM


May 7, 2024 04:30PM Jasper Therapeutics to Present at Upcoming Investor Conferences in May
Mar 28, 2024 06:21AM RBC Capital Starts Jasper Therapeutics (JSPR) at Outperform
Feb 6, 2024 09:00AM Jasper Therapeutics (JSPR) Announces Pricing of $50 Million Underwritten Offering of Common Stock
Feb 6, 2024 08:59AM Jasper Therapeutics Announces Pricing of $50 Million Underwritten Offering of Common Stock